Bioequivalence of a slow-release and a non-retard formulation of isradipine

DG Holmes, K Kutz - American journal of hypertension, 1993 - academic.oup.com
Pharmacokinetic studies were carried out in 48 healthy male volunteers to determine the
pharmacokinetic properties of an ew modified-release formulation of isradipine (SRO) and to …
被引用次数：16 相关文章

[引用][C] Bioequivalence of a slow-release and a non-retard formulation of isradipine

DG HOLMES, K KUTZ - American journal of hypertension, 1993 - pascal-francis.inist.fr
Bioequivalence of a slow-release and a non-retard formulation of isradipine CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Bioequivalence of a slow-release and a non-retard formulation of isradipine.

DG Holmes, K Kutz - American Journal of Hypertension, 1993 - europepmc.org
Pharmacokinetic studies were carried out in 48 healthy male volunteers to determine the
pharmacokinetic properties of a new modified-release formulation of isradipine (SRO) and to …

Bioequivalence of a slow-release and a non-retard formulation of isradipine

DG Holmes, K Kutz - American journal of hypertension, 1993 - pubmed.ncbi.nlm.nih.gov
Pharmacokinetic studies were carried out in 48 healthy male volunteers to determine the
pharmacokinetic properties of a new modified-release formulation of isradipine (SRO) and to …

[引用][C] Bioequivalence of a slow-release and a non-retard formulation of isradipine

DG HOLMES, K KUTZ - American journal of hypertension, 1993 - Nature Publishing Group